Radionuclide ventriculography phase analysis for risk stratification of patients undergoing cardiotoxic cancer therapy

BACKGROUND: Accurate diagnostic tools to identify patients at risk of cancer therapy-related cardiac dysfunction (CTRCD) are critical. For patients undergoing cardiotoxic cancer therapy, ejection fraction assessment using radionuclide ventriculography (RNVG) is commonly used for serial assessment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, K. A., Small, A. D., Ray, S., Hamilton, D. J., Martin, W., Robinson, J., Goodfield, N. E. R., Paterson, C. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993717/
https://www.ncbi.nlm.nih.gov/pubmed/32748278
http://dx.doi.org/10.1007/s12350-020-02277-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8993717/
https://www.ncbi.nlm.nih.gov/pubmed/32748278
http://dx.doi.org/10.1007/s12350-020-02277-z

Ejemplares similares